Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae.

Eitemau Tebyg

• Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.
  gan: Hardy, D J, et al.
  Cyhoeddwyd: (1990)
• Activity of a new carbapenem antibiotic, meropenem, against Haemophilus influenzae strains with beta-lactamase- and non-enzyme-mediated resistance to ampicillin.
  gan: Jorgensen, J H, et al.
  Cyhoeddwyd: (1991)
• Quantitative antimicrobial susceptibility testing of Haemophilus influenzae and Streptococcus pneumoniae by using the E-test.
  gan: Jorgensen, J H, et al.
  Cyhoeddwyd: (1991)
• Comparative activities of LY 164846 and other orally administered beta-lactam antibiotics against Haemophilus influenzae.
  gan: Jorgensen, J H, et al.
  Cyhoeddwyd: (1986)
• In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae.
  gan: Jorgensen, J H, et al.
  Cyhoeddwyd: (1986)